Aragon-Martinez, O.H.; González-Chávez, M.M.; Galicia-Cruz, O.G.; Méndez-Gallegos, S.d.J.; Isiordia-Espinoza, M.A.; Martinez-Morales, F.
Evaluation of Dactylopius opuntiae Extract for Xanthine Oxidase Inhibition and Serum Uric Acid Reduction in a Hyperuricemic Mouse Model. Pharmaceuticals 2024, 17, 1575.
https://doi.org/10.3390/ph17121575
AMA Style
Aragon-Martinez OH, González-Chávez MM, Galicia-Cruz OG, Méndez-Gallegos SdJ, Isiordia-Espinoza MA, Martinez-Morales F.
Evaluation of Dactylopius opuntiae Extract for Xanthine Oxidase Inhibition and Serum Uric Acid Reduction in a Hyperuricemic Mouse Model. Pharmaceuticals. 2024; 17(12):1575.
https://doi.org/10.3390/ph17121575
Chicago/Turabian Style
Aragon-Martinez, Othoniel H., Marco M. González-Chávez, Othir G. Galicia-Cruz, Santiago de J. Méndez-Gallegos, Mario A. Isiordia-Espinoza, and Flavio Martinez-Morales.
2024. "Evaluation of Dactylopius opuntiae Extract for Xanthine Oxidase Inhibition and Serum Uric Acid Reduction in a Hyperuricemic Mouse Model" Pharmaceuticals 17, no. 12: 1575.
https://doi.org/10.3390/ph17121575
APA Style
Aragon-Martinez, O. H., González-Chávez, M. M., Galicia-Cruz, O. G., Méndez-Gallegos, S. d. J., Isiordia-Espinoza, M. A., & Martinez-Morales, F.
(2024). Evaluation of Dactylopius opuntiae Extract for Xanthine Oxidase Inhibition and Serum Uric Acid Reduction in a Hyperuricemic Mouse Model. Pharmaceuticals, 17(12), 1575.
https://doi.org/10.3390/ph17121575
